HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert A Figlin Selected Research

Prostatic Neoplasms (Prostate Cancer)

12/2020Combination Androgen Receptor Inhibition and Docetaxel in Metastatic Castration-sensitive Prostate Cancer: The Next Step in First-line Treatment?
1/2020COVID-19 and androgen-targeted therapy for prostate cancer patients.
1/2017Circulating tumor cells in prostate cancer: beyond enumeration.
12/2015Clinical and Translational Assessment of VEGFR1 as a Mediator of the Premetastatic Niche in High-Risk Localized Prostate Cancer.
8/2005Carbonic anhydrase IX and the future of molecular markers in renal cell carcinoma.
5/2004Phase I trial of antigen-specific gene therapy using a recombinant vaccinia virus encoding MUC-1 and IL-2 in MUC-1-positive patients with advanced prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert A Figlin Research Topics

Disease

120Renal Cell Carcinoma (Grawitz Tumor)
04/2023 - 09/2002
71Neoplasms (Cancer)
11/2022 - 02/2003
17Neoplasm Metastasis (Metastasis)
01/2020 - 02/2003
15Kidney Neoplasms (Kidney Cancer)
05/2014 - 01/2003
8Hypertension (High Blood Pressure)
04/2023 - 12/2003
8Fatigue
04/2023 - 01/2007
8Hypoxia (Hypoxemia)
01/2018 - 10/2003
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2015 - 06/2006
6Prostatic Neoplasms (Prostate Cancer)
12/2020 - 05/2004
5Carcinoma (Carcinomatosis)
12/2005 - 02/2003
4Disease Progression
01/2014 - 04/2006
3Diarrhea
04/2023 - 01/2007
3Hand-Foot Syndrome
04/2023 - 10/2008
3Carcinogenesis
11/2008 - 03/2005
2Brain Neoplasms (Brain Tumor)
10/2019 - 03/2010
2Colorectal Neoplasms (Colorectal Cancer)
12/2012 - 01/2008
2Dyspnea (Shortness of Breath)
09/2010 - 10/2008
2Lung Neoplasms (Lung Cancer)
07/2010 - 11/2008
2Exanthema (Rash)
10/2008 - 08/2008
2Neutropenia
10/2008 - 11/2003
2Cachexia
05/2004 - 11/2003
2Thrombosis (Thrombus)
02/2004 - 03/2003
1COVID-19
01/2020
1Anemia
01/2018
1Edema (Dropsy)
01/2018
1Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2017
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2017
1Hypercholesterolemia
10/2016
1Hyperglycemia
10/2016
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2016
1Clear-cell metastatic renal cell carcinoma
01/2015

Drug/Important Bio-Agent (IBA)

24Sunitinib (Sutent)FDA Link
04/2023 - 01/2006
16Biomarkers (Surrogate Marker)IBA
01/2019 - 06/2004
14Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2017 - 10/2003
14TOR Serine-Threonine KinasesIBA
10/2016 - 10/2006
11Proteins (Proteins, Gene)FDA Link
10/2014 - 05/2003
10Interferon-alpha (Interferon Alfa)IBA
04/2023 - 01/2007
10Interleukin-2 (IL2)IBA
02/2015 - 08/2003
10Carbonic Anhydrase IXIBA
10/2014 - 02/2003
8temsirolimusFDA Link
01/2013 - 11/2007
7InterferonsIBA
06/2014 - 09/2007
6Tyrosine Kinase InhibitorsIBA
01/2019 - 01/2009
6Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2016 - 01/2006
6VaccinesIBA
01/2015 - 01/2003
6Sorafenib (BAY 43-9006)FDA Link
02/2014 - 08/2008
6Bevacizumab (Avastin)FDA Link
09/2011 - 10/2007
5Erlotinib Hydrochloride (CP 358,774)FDA Link
09/2015 - 06/2006
5AntigensIBA
07/2013 - 11/2003
5MTOR InhibitorsIBA
12/2012 - 10/2006
5CytokinesIBA
08/2012 - 08/2003
5Monoclonal AntibodiesIBA
11/2010 - 03/2004
4RNA (Ribonucleic Acid)IBA
11/2022 - 07/2013
4pazopanibFDA Link
12/2017 - 01/2010
4EverolimusFDA Link
10/2016 - 08/2008
3Docetaxel (Taxotere)FDA Link
12/2020 - 11/2003
3Hemoglobins (Hemoglobin)IBA
06/2017 - 05/2004
3Celecoxib (Celebrex)FDA Link
09/2015 - 06/2006
3Tumor Biomarkers (Tumor Markers)IBA
10/2014 - 09/2004
3Phosphatidylinositols (Phosphatidylinositol)IBA
08/2013 - 08/2009
3LigandsIBA
06/2008 - 10/2005
3Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
11/2003 - 03/2003
2AndrogensIBA
12/2020 - 01/2020
2Androgen Receptors (Androgen Receptor)IBA
12/2020 - 01/2020
2CD40 Ligand (CD40L)IBA
01/2020 - 01/2015
2Transcription Factors (Transcription Factor)IBA
01/2020 - 01/2010
2PT2385IBA
01/2020 - 01/2018
2Angiogenesis InhibitorsIBA
01/2016 - 11/2013
2Mechanistic Target of Rapamycin Complex 2IBA
08/2013 - 01/2013
2Mechanistic Target of Rapamycin Complex 1IBA
08/2013 - 01/2013
2Peptides (Polypeptides)IBA
07/2013 - 05/2004
2Platelet-Derived Growth FactorIBA
01/2010 - 01/2006
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
12/2009 - 10/2006
2ChemokinesIBA
06/2008 - 05/2007
2Interleukin-4 (Interleukin 4)IBA
11/2003 - 03/2003
1abirateroneIBA
12/2020
1Anti-Bacterial Agents (Antibiotics)IBA
12/2019
1Circulating Tumor DNAIBA
01/2019
1Lactic Acid (Lactate)FDA LinkGeneric
06/2017
1Imatinib Mesylate (Gleevec)FDA Link
01/2017
1Vascular Endothelial Growth FactorsIBA
01/2016
1thiamine triphosphorate (TTP)IBA
01/2016
1Axitinib (AG 013736)IBA
12/2015
1Dinoprostone (PGE2)FDA Link
09/2015
1B7-H1 AntigenIBA
02/2015
1aldesleukin (Proleukin)FDA Link
02/2015
1Angiopoietin-2IBA
10/2014
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
10/2014
1RamucirumabIBA
06/2014
1NucleolinIBA
02/2014
1Nucleotide AptamersIBA
02/2014

Therapy/Procedure

65Therapeutics
12/2020 - 12/2002
27Nephrectomy
11/2016 - 09/2002
24Immunotherapy
01/2020 - 09/2002
4Drug Therapy (Chemotherapy)
10/2008 - 10/2003
2Thrombectomy
02/2004 - 03/2003
1Castration
12/2020
1Duration of Therapy
10/2016
1Precision Medicine
01/2016
1Secondary Prevention
01/2015
1Neoadjuvant Therapy
05/2014